Product Information
ROPINIROLE HCL 4 MG TABLET is a generic product labeled by Glenmark Pharmaceuticals Inc., USA, priced at $0.0804 per EA under NDC 68462025801. Its NADAC has been published 657 times since Nov 28, 2013.
Strength
4 mg/1
Manufacturer
Glenmark Pharmaceuticals Inc., USANDC
68462025801
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
ROPINIROLE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA090135On Market Since
2/25/2010
Pharmacological Classes
Price Statistics
The NADAC for ROPINIROLE HCL 4 MG TABLET has been published 657 times since Nov 28, 2013, and over the history we have for it it has declined 29.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0804 per EA |
|---|---|
| All-time high | $0.1515 (Mar 12, 2014) |
| All-time low | $0.0681 (Nov 20, 2024) |
| 52-week high | $0.0852 |
| 52-week low | $0.0771 |
| Median price | $0.0991 |
| Average price | $0.1004 |
| Largest weekly change | +41.3% (Dec 22, 2021) |
| Weeks tracked | 657 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 2 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 2 manufacturers (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 11% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of ROPINIROLE HCL 4 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for ROPINIROLE HCL 4 MG TABLET, manufactured by Glenmark Pharmaceuticals Inc., USA, is $0.0804 per EA (NDC 68462025801), effective Jun 24, 2026.
How has the price of ROPINIROLE HCL 4 MG TABLET changed over time?
Over the history we have for it, the NADAC for ROPINIROLE HCL 4 MG TABLET has declined 29.4%. It has been tracked across 657 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for ROPINIROLE HCL 4 MG TABLET?
Since Nov 28, 2013, the NADAC for ROPINIROLE HCL 4 MG TABLET has ranged from a low of $0.0681 (Nov 20, 2024) to a high of $0.1515 (Mar 12, 2014), with a median of $0.0991 per EA.
Are there cheaper alternatives to ROPINIROLE HCL 4 MG TABLET?
Yes. 2 NADAC-published products share the same active ingredient, strength, and dosage form. The lowest-priced option, ROPINIROLE HCL 4 MG TABLET, is $0.0713 per EA — about 11% below ROPINIROLE HCL 4 MG TABLET.
Who manufactures ROPINIROLE HCL 4 MG TABLET?
ROPINIROLE HCL 4 MG TABLET (NDC 68462025801) is labeled by Glenmark Pharmaceuticals Inc., USA, and CMS classifies it as a generic product.
Related Drugs
Same classification